RHT Health Trust makes changes to board following Fortis sale
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
RHT Health Trust Manager, as the trustee-manager of RHT Health Trust, announced on Monday a reconstitution of the trust's board.
The move followed the completed sale of the trust's entire portfolio of healthcare assets to its controlling unitholder Fortis Healthcare for about S$895.55 million. The sale was completed in January.
The members of the board have, from Monday, stepped down. They are: Vivek Mehra as non-executive chairman and independent director; Eng Meng Leong as independent director; Sydney Michael Hwang as independent director; Yogendra Nath Mathur as lead independent director; Peter Joseph Seymour Rowe as independent director; Daljit Singh as non-independent non-executive director; and Gurpreet Singh Dhillon as executive director.
The trust also announced the appointment of Tan Bong Lin as non-executive chairman and independent director; Ronnie Tan Keh Poo as independent director; and Wong Chiang Yin as independent director.
Copyright SPH Media. All rights reserved.
TRENDING NOW
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Beijing’s calculated silence on the Iran war
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Vietnam formalises new state leadership, redefining ‘four pillars’ power balance
